Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)

SHE:300239 Revenue

Baotou Dongbao Bio-Tech Co.,Ltd had revenue of 207.92M CNY in the quarter ending September 30, 2026, with 26.98% growth. This brings the company's total for the last twelve months to 835.12M, up 6.44% year-over-year. In the year 2025, Baotou Dongbao Bio-Tech Co.,Ltd had annual revenue of 745.31M, down -15.78%. That makes Baotou Dongbao Bio-Tech Co.,Ltd the 20,960th largest company in the world by revenue and 3,843rd in China.

• Revenue (ttm): 835.12M
• Revenue Growth: +6.44%
• P/S Ratio: 3.36
• Revenue / Employee: 586.46K
• Employees: 1,424
• Market Cap: 2.80B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 266.98M 35.8%
• North China 221.03M 29.7%
• South-West China 66.44M 8.9%
• Southern China 51.31M 6.9%
• Northwestern China 48.80M 6.5%
• Northeast China 32.79M 4.4%
• Overseas 32.27M 4.3%
• Central China 25.68M 3.4%

Fiscal year ended Dec 31, 2025 See the full SHE:300239 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	745.31M	-139.62M	-15.78%
Dec 31, 2024	884.93M	-89.58M	-9.19%
Dec 31, 2023	974.51M	31.12M	3.30%
Jan 1, 2023	943.40M	331.23M	54.11%
Jan 1, 2022	612.17M	163.34M	36.39%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error